Progression of Retinopathy in Type 1 Diabetes

  • Research type

    Research Study

  • Full title

    Impact of insulin pump therapy and islet transplantation on progression of diabetic retinopathy in Type 1 diabetes.

  • IRAS ID

    211912

  • Contact name

    Shareen Forbes

  • Contact email

    Shareen.Forbes@ed.ac.uk

  • Sponsor organisation

    University of Edinburgh

  • Duration of Study in the UK

    3 years, 0 months, 0 days

  • Research summary

    Diabetes is a major cause of blindness. High blood glucose readings are associated with progressive complications from diabetes including those affecting the retina termed diabetic retinopathy.
    When patients are switched to insulin pump therapy or undergo islet transplantation – a procedure involving the transplantation of donor islets into the liver which may lead to insulin independence, an improvement in their diabetes control may occur leading to an improvement in diabetic retinopathy in the longer term. However, following commencement of insulin pump therapy those with poor control and pre-existing diabetic retinopathy are susceptible to progression in diabetic retinopathy within the first year of therapy. Retinal eye screening allows the physician to intervene with therapy which might save eyesight. Therefore it is important to understand the particular patient groups may be most at risk for eye disease and the best time at which to perform retinal screening.

    We will follow subjects who have undergone conversion to insulin pump therapy or islet transplantation and serially examine their vision prior to and after this therapeutic intervention and relate changes in retinopathy to changes in their glucose control. We will use novel techniques of examining glucose control including Continuous Glucose Monitoring Systems which record glucose concentrations every three minutes over a six-day period. These tests will allow us to examine whether progression of retinopathy is related more to the improvement of blood glucose control per se or to a reduction in hyperglycaemia or a reduction in blood glucose variability. The study will also allow us to make objective assessments of nerve fibres by measuring vibration sensation in the feet and how this perception changes over time and its relationship to blood glucose control. The study will help inform screening strategies for islet transplantation and help refine those for insulin pump subjects, leading to improved medical outcomes.

  • REC name

    South East Scotland REC 01

  • REC reference

    16/SS/0198

  • Date of REC Opinion

    30 Dec 2016

  • REC opinion

    Further Information Favourable Opinion